Literature DB >> 31235161

Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients.

Reham F Amin1, Amal S El Bendary2, Sherif E Ezzat3, Waleed S Mohamed4.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) was considered one of the most common causes of chronic liver disease and is considered the hepatic manifestation of type 2 diabetes mellitus (T2DM). The factors that lead to marked fibrosis and liver cell injury in NAFLD are still remaining undiscovered. PATIENTS AND METHODS: This study included (40) type 2 diabetic patients with NAFLD and (40) diabetic patients without NAFLD beside 15 healthy persons as a control group. All of them were subjected to full history taking, thorough clinical examination with especial stress on body weight (BW), height, body mass index (BMI), waist-hip ratio, blood pressure. Laboratory tests included serum total cholesterol (TC), triglycerides (TG), low density lipoprotein (LDL) and high-density lipoprotein (HDL), fasting blood glucose (FBG) and 2-h postprandial blood glucose (PBG), serum Ferritin and urine microalbuminuria (MAU).
RESULTS: Duration of diabetes, BW, BMI and blood pressure were significantly higher in NAFLD group (P = 0.001). FBG, PBG, TC, TG, LDL, serum Ferritin and MAU were significantly increased in NAFLD group with significant difference between two studied groups as regard HDL. There was a highly significant correlation between serum Ferritin with BW, BMI, duration of diabetes, TC, TG, LDL and MAU. There was a significant correlation between serum Ferritin with age, waist hip ratio, duration of diabetes, SBP, FBG, PBG and HDL. There was a significant correlation between MAU and age, weight, BMI, waist hip ratio, duration of diabetes, DBP, FBG TC, TG, LDL and HDL.
CONCLUSION: NAFLD is a common liver disorder in diabetic patients. NAFLD is significantly associated with microalbuminuria and elevated serum Ferritin.
Copyright © 2019 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Microalbuminuria; Non-alcoholic fatty liver disease; Serum ferritin; Type 2 diabetes mellitus

Year:  2019        PMID: 31235161     DOI: 10.1016/j.dsx.2019.05.030

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  5 in total

Review 1.  Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD.

Authors:  Viera Kupčová; Michaela Fedelešová; Jozef Bulas; Petra Kozmonová; Ladislav Turecký
Journal:  Int J Environ Res Public Health       Date:  2019-09-24       Impact factor: 3.390

Review 2.  Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19.

Authors:  Aparajita Sen; Arti Nigam; Meenakshi Vachher
Journal:  Int J Pept Res Ther       Date:  2022-01-24       Impact factor: 2.191

3.  Serum ferritin is correlated with non-alcoholic fatty liver disease in middle-aged and older patients with type 2 diabetes.

Authors:  Jun-Xin Yan; Bin-Jing Pan; Ping-Ping Zhao; Li-Ting Wang; Jing-Fang Liu; Song-Bo Fu
Journal:  Endocr Connect       Date:  2021-11-29       Impact factor: 3.335

4.  Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study.

Authors:  Jun-Wei Wang; Chun-Hua Jin; Jiang-Feng Ke; Yi-Lin Ma; Yu-Jie Wang; Jun-Xi Lu; Mei-Fang Li; Lian-Xi Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-05       Impact factor: 6.055

5.  Animal Fat Intake Is Associated with Albuminuria in Patients with Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome.

Authors:  Manuela Abbate; Catalina M Mascaró; Sofía Montemayor; María Barbería-Latasa; Miguel Casares; Cristina Gómez; Lucia Ugarriza; Silvia Tejada; Itziar Abete; María Ángeles Zulet; Antoni Sureda; J Alfredo Martínez; Josep A Tur
Journal:  Nutrients       Date:  2021-05-04       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.